Insulin Therapy Center

Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.

In this week's Homerun Slides, approaches to intensifying therapy in patients who are using basal insulin but are not yet at goal.

Closed-loop system at home over 12 weeks feasible in type 1 patients.

Twice I have had patients re-admit to inpatient care after repetition of DKA within 48 hours of last admission. Clearly, the patients were not receiving insulin.

In this week's Homerun Slides, lessons from the ORIGIN Trial and insulin effects on human islet function.

Short and long sleep duration have negative effect on insulin sensitivity in men, increase in beta-cell function in women

Finding a new pathway to manage insulin production is a large step towards improving outcomes for patients with diabetes.

In this week's Homerun Slides, we look at the pro and contra arguments for forcing of early Insulin Therapy in patients with Type 2 Diabetes...

FDA approved new long-acting insulin degludec for treatments of diabetes mellitus.

Lack of resuspension alters PK/PD and result in poor glycemic controls.